Real-time enrollment status for this myeloablative allogeneic hematopoietic cell transplantation clinical trial
Current Status
Recruiting
Checked: August 30, 2026 at 9:31 AM UTC
| NCT Number | NCT05335434 |
| Recruiting Status | Recruiting |
| Condition | Myeloablative Allogeneic Hematopoietic Cell Transplantation |
| Phase | NA |
| Target Enrollment | 20 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Dana-Farber Cancer Institute |
| Last Updated on CT.gov | December 15, 2025 (Dec 15, 2025) |
As of August 30, 2026: Clinical trial NCT05335434 is currently recruiting participants. This na study for myeloablative allogeneic hematopoietic cell transplantation is actively seeking new participants at 1 location across the United States. The study is sponsored by Dana-Farber Cancer Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05335434 is actively recruiting participants as of August 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05335434 was last updated Dec 15, 2025 (December 15, 2025). HelloStudys verifies this status automatically.